NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION
Clinical trials for NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye injection aims to reduce treatment burden for wet AMD patients
Disease control Not yet recruitingThis study tests a new medicine called AIV007 for people with wet age-related macular degeneration, a condition that causes vision loss. About 35 participants will receive either AIV007 or the standard treatment Eylea to see if AIV007 can improve vision and require fewer follow-u…
Matched conditions: NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: AiViva BioPharma, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New syringe design aims to simplify eye injections for common vision disorders
Disease control Not yet recruitingThis study tests whether a new prefilled syringe (SCD411) is easy and safe for eye doctors to use when treating wet age-related macular degeneration, retinal vein occlusion, diabetic macular edema, or diabetic retinopathy. About 33 doctors will use the syringe and researchers wil…
Matched conditions: NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION
Phase: PHASE2 • Sponsor: Sam Chun Dang Pharm. Co. Ltd. • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
New study aims to keep macular disease patients on track with eye injections
Knowledge-focused Not yet recruitingThis study tests whether a personalized care approach helps patients with chronic macular diseases (like wet age-related macular degeneration and diabetic macular edema) attend their regular eye injection appointments. Many patients skip these vital treatments, risking vision los…
Matched conditions: NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Singapore Eye Research Institute • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC